About Reliance Life Sciences Private Limited
Data last updated:
Reliance Life Sciences Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 30 January 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2001PTC130654. Its GSTIN is 27AABCR7594L1ZO (Maharashtra). The company holds 12 GST registrations, of which 10 are active.
The company has an authorised share capital of ₹126.01 Cr and a paid-up capital of ₹96.01 Cr. It is led by directors including Venkata Ramana (Whole-Time Director) and Shailaja Gada Saxena (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,615.3 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹437.63 Cr (net margin 16.7%) and EBITDA of ₹830.58 Cr (EBITDA margin 31.8%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
The company has about 1,656 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Reliance Life Sciences. As per MCA filings, the company has open charges of ₹1,880.61 Cr and satisfied charges of ₹201.13 Cr on record. Court records list 54 cases involving the company, including 35 filed by the company and 19 filed against it; 7 cases are pending. The company has 20 deals on record (14 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹135.75 Cr; the latest was in March 2025.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rellife.com.
Company details
Contact details
Reliance Life Sciences Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is rellife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressDhirubhai Ambani Life Sciences Centre R – 282 Ttc Area Of MIDC Thane Belapur Ro, Ad Rabale, Navi Mumbai, Maharashtra, India – 400701
- IndustryLife Sciences, Biotechnology
To see the full contact details of Reliance Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Reliance Life Sciences operates one associated brand: Reliance Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Clinical research, regenerative medicine, and specialty pharmaceuticals are provided. | rellife.com |
Business activity
The main business activities of Reliance Life Sciences are manufacturing, professional, scientific and technical and hospital and medical care. 4 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | |
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Reliance Life Sciences Private Limited, buy the company report.
Financials of Reliance Life Sciences Private Limited
FY 2025 filings availableReliance Life Sciences Private Limited reported revenue of ₹2,615.3 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over three years, including 15% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2,615.3 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹830.58 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹437.63 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.8% | ||||
| Net Profit Margin | 16.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reliance Life Sciences Private Limited, buy the company report.
Board of directors of Reliance Life Sciences Private Limited
Reliance Life Sciences has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Ramana | Whole-Time Director | 10 Jan 2022 | 4 Years 10 Months | Current |
| Laxmidas Vallabhdas Merchant Also directs: Kamalakar Enterprises LLP, Narahari Enterprises LLP, B. D. Industries (Pune) Limited and 5 more | Director | 01 Jun 2007 | 19 Years 5 Months | Current |
| Shailaja Gada Saxena | Whole-Time Director | 30 Sep 2022 | 4 Years 1 Months | Current |
| Ramaprasad Jayaraman Also directs: Reliance Life Sciences Nashik Private Limited | Whole-Time Director | 01 Jul 2016 | 10 Years 4 Months | Current |
| Vinay Arvind Ranade Also directs: Reliance Life Sciences Nashik Private Limited | Whole-Time Director | 01 Jul 2016 | 10 Years 4 Months | Current |
Auditor
Reliance Life Sciences Private Limited is audited by Chaturvedi & Shah LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chaturvedi & Shah LLP | FY 2025 | 101720W/W100355 |
Shareholding
The shareholding of Reliance Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Reliance Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 May 2025 | 101099053 | State Bank of India | ₹25 Cr | Open | |
| 09 Apr 2025 | 101090534 | Others | ₹500 Cr | Open | |
| 29 Mar 2025 | 101077140 | Canara Bank | ₹5.6 Cr | Open | |
| 21 Mar 2025 | 101069823 | State Bank of India | ₹1.06 Lakh | Open | |
| 22 Feb 2024 | 100882153 | Others | ₹1,000 Cr | Open |
To see the full charge records of Reliance Life Sciences Private Limited, buy the company report.
Total charge records: 17 View all charges
Deals & funding
Reliance Life Sciences Private Limited has 20 deals on record (14 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹135.75 Cr; the latest was in March 2025.
Deals on record (5 of 20)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Seller: Nashoba Trading Company LLP |
| Jul 2020 | Secondary share transfer | Undisclosed | Seller: Reliance Industries Holding Private Limited |
| Mar 2017 | Rights issue | ₹96 Cr | Investors: Reliance Research and Development Services Private Limited , Reliance Health and Technology Private Limited , Healthcare Systems and Solutions Global Private Limited |
| Mar 2017 | Secondary share transfer | Undisclosed | Seller: Reliance Industries Holding Private Limited |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: Reliance Research and Development Services Private Limited , Saffron Trading Company LLP , Nashoba Trading Company LLP Seller: Reliance Web Spiders.Com Private Limited , Reliance Qualnet.Com Private Limited , Reliance Industries Holding Private Limited |
To see the full deal history of Reliance Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Reliance Life Sciences Private Limited has 54 court cases on record: 35 filed by Reliance Life Sciences, 19 filed against it. 7 cases are pending and 47 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 26 | 9 | 7 |
| District courts | 16 | 9 | 0 |
| Supreme Court | 12 | 1 | 0 |
Cases on record (5 of 54)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Arbitration matter | Filed against the company by M/S HDFC Bank Limited Th. Mayuri Kalpesh Jadhav | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Roche Products (India) Private Limited Through Its Authorised Representative Through Its Authorised Representative Vivek Kashyap 1503, 15Th Floor, the Capital, Bandra Kurla Complex, , District: Bandra (East) ,Mumbai , Maharashtra and 2 others | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed by the company against Roche Products (India) Private Limited Office at 1503, 15Th Floor, the Capital, Bandra Kurla Complex Bandra (East) , District: Mumbai ,Mumbai , Maharashtra and 4 others | Disposed |
| District court, Jamnagar, Gujarat | Criminal complaint | Filed by the company against M/S Manas Fruits Processors Pvt. Ltd. | Disposed |
| High Court, TELANGANA | Arbitration matter | Filed by the company against Dr. Reddy's Laboratories Limited, | Disposed |
To see the full case history of Reliance Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Reliance Life Sciences Private Limited was last rated by Care on 21 Feb 2023.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 21 Feb 2023 |
To see the full credit ratings and regulatory alerts of Reliance Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reliance Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Reliance Life Sciences has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Reliance Life Sciences Nashik Private Limited | U24100MH2022PTC377003 |
To see the full group structure of Reliance Life Sciences Private Limited, buy the company report.
Employees & EPFO
Reliance Life Sciences Private Limited has a workforce of 1,656 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1,656 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Reliance Life Sciences Private Limited, buy the company report.
GST
Reliance Life Sciences has 12 GST registrations: 10 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCR7594L1ZO | Maharashtra | Active | 01 Jul 2017 |
| 27AABCR7594L2ZN | Maharashtra | Active | 02 Jul 2017 |
| 07AABCR7594L1ZQ | Delhi | Active | 01 Jul 2017 |
| 09AABCR7594L1ZM | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Reliance Life Sciences Private Limited, buy the company report.
Recent activity
Reliance Life Sciences Private Limited has 15 board changes on record since 2007: 5 appointments and 10 cessations. The latest: Shailaja Gada Saxena was appointed as Whole-Time Director on 30 Sep 2022.
36 earlier events are in the company report.
News
Frequently asked questions
Reliance Life Sciences is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 30 January 2001 (25+ years old) and is registered under CIN U24239MH2001PTC130654.
Reliance Life Sciences has 5 current directors:
- Venkata Ramana - Whole-Time Director
- Shailaja Gada Saxena - Whole-Time Director
- Ramaprasad Jayaraman - Whole-Time Director
- Vinay Arvind Ranade - Whole-Time Director
- Laxmidas Vallabhdas Merchant - Director
The latest financial statements of Reliance Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Reliance Life Sciences is 27AABCR7594L1ZO, registered in Maharashtra. The company has 12 GST registrations in all, of which 10 are active and 2 are cancelled or inactive. Other active GSTINs include 27AABCR7594L2ZN (Maharashtra), 07AABCR7594L1ZQ (Delhi), 09AABCR7594L1ZM (Uttar Pradesh).
The CIN (Corporate Identification Number) of Reliance Life Sciences is U24239MH2001PTC130654. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reliance Life Sciences has 54 court cases on record: 35 filed by the company and 19 filed against it. 7 are pending. Most are in the high courts.
Reliance Life Sciences was incorporated on 30 January 2001, making it 25+ years old. It is registered with the Registrar of Companies, Mumbai.
Reliance Life Sciences has 20 deals on record (14 secondary share transfers, 5 funding rounds, 1 rights issue), with disclosed funding of ₹135.75 Cr; the latest was in March 2025.
Shailaja Gada Saxena was appointed as Whole-Time Director on 30 Sep 2022. Shailaja Gada Saxena ceased to be Director on 30 Sep 2022. Dinesh Bhaskar Sathe ceased to be Director on 10 Jan 2022. Reliance Life Sciences has 15 board changes on record in total.
Reliance Life Sciences can be reached through the website rellife.com. Its registered office is in Navi Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
